Temozolomide Patents

Given below is the list of patents protecting Temozolomide, along with the drug name that holds that patent and the company name owning that drug.

A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Temozolomide's patents.

Latest Legal Activities on Temozolomide's Patents

Given below is the list recent legal activities going on the following patents of Temozolomide.

Activity	Date	Patent Number
Today's Critical Events
Payment of Maintenance Fee, 12th Year, Large Entity	13 Jan, 2022	US7786118
Payment of Maintenance Fee, 8th Year, Large Entity	17 Jan, 2018	US7786118
Correspondence Address Change Critical	26 Aug, 2011	US7786118
Correspondence Address Change Critical	26 Aug, 2011	US6987108
Post Issue Communication - Certificate of Correction	09 Feb, 2011	US7786118
Recordation of Patent Grant Mailed Critical	31 Aug, 2010	US7786118
Patent Issue Date Used in PTA Calculation Critical	31 Aug, 2010	US7786118
Issue Notification Mailed Critical	11 Aug, 2010	US7786118
Application Is Considered Ready for Issue Critical	03 Aug, 2010	US7786118
Dispatch to FDC	03 Aug, 2010	US7786118